AION UT Debuts in Hong Kong: GAC Showcases 8 Flagship Models at 2025 International Automotive & Supply Chain Expo (Hong Kong)
HONG KONG, June 13, 2025 /PRNewswire/ -- On June 12, the 2025 International Automotive & Supply Chain Expo (Hong Kong) opened. GAC showcased eight flagship models across its three major product-brands: GAC, AION, and HYPTEC—while unveiling "Hong Kong ACTION" – the localized implementation of its "One GAC 2.0" strategy – and announcing the global debut of GOVY AirCab, its first mass-produced flying car, alongside the Hong Kong debut of AION UT.
At this year's expo, GAC showcased eight models, four of which have already been launched in Hong Kong. The AION Y PLUS features quality, safety, and long-range capabilities, its seats can be fully reclined flat. The AION V, with high quality, high technology, and high safety, caters to the needs of families worldwide. The HYPTEC HT, a luxurious and intelligent electric SUV, features a stylish appearance and is equipped with seat ventilation, heating, and massage, providing users with exceptional travel experiences. The E9 PHEV received hundreds of orders upon its launch in Hong Kong in 2024, has gained popularity for combining luxury with strong performance, becoming a top choice in the new energy MPV segment.
The AION UT, GAC's global strategic model, made its regional debut. Designed by GAC's Milan Design Center, it features a bold aesthetic, spacious cabin, and AI voice assistant. Meeting both Chinese and European five-star safety standards, the AION UT will go on sale in Hong Kong later this year, offering a stylish and intelligent electric option for urban consumers.
Leveraging Hong Kong's influence on Southeast Asia's right-hand drive market, vehicles showcased at the expo also target the global right-hand drive market, which accounts for 30% of total vehicle sales worldwide. Consequently, GAC is accelerating its overseas production capacity layout. GAC's Indonesia Smart Factory, which commenced operations on June 12, will radiate across the ASEAN region.
At the expo, GAC officially unveiled the GOVY AirCab, advancing the development of the low-altitude economic ecosystem guided by the concept of "worry-free travel by 'one click'". GAC's self-developed third-generation GoMate humanoid robot served as the intelligent reception officer at the booth. It will be applied in public safety and other fields to support smart city development.
GAC remains committed to high value, pursuing a global expansion with distinctive GAC characteristics, and aims to deliver experiences that exceed expectations for global consumers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
an hour ago
- Korea Herald
Novogene Establishes New Subsidiary in Korea to Accelerate Multi-Omics Research
SEOUL, South Korea, June 23, 2025 /PRNewswire/ -- Novogene, a global leader in next-generation sequencing (NGS) and multi-omics solutions, today announced the establishment of Novogene Korea Limited, a wholly owned subsidiary headquartered in Seoul. This strategic expansion deepens Novogene's long-standing engagement with Korea's biomedical and biotech sectors, reinforcing its commitment to delivering rapid, high-quality, and cost-effective multi-omics services tailored to local research needs. The new entity provides localized customer support, shorter project timelines, and stronger collaboration with Korea's vibrant scientific community — spanning cancer genomics, microbiome studies, precision medicine, and agricultural genomics. Novogene empowers researchers to accelerate discoveries across genomics, transcriptomics, proteomics, metabolomics, and beyond. "South Korea is a global innovation hub, and by establishing a dedicated team in Seoul, we are investing in the future of multi-omics discovery," said Justin Lee, Vice President, Novogene Asia Pacific, Middle East & Africa (AMEA). "With the launch of Novogene Korea, we are even better positioned to support our customers with rapid, cost-effective, and reliable services that are already trusted by more than 7,300 organizations worldwide. We sincerely thank the Korean scientific community for their continued trust and collaboration in advancing the frontiers of science." Backed by robust government R&D support, world-class academic institutions, and a dynamic biotech ecosystem, South Korea is uniquely positioned to lead the next wave of genomic innovation. Novogene Korea will partner closely with universities, start-ups, and research hospitals to help unlock transformative insights in health, agriculture, and beyond. About Novogene Novogene is a global leader in applying cutting-edge molecular biology technologies and high-performance computing to advance life science and human health research. With one of the world's largest sequencing capacities, Novogene delivers industry-leading multi-omics solutions to academic institutions, clinical researchers, and pharmaceutical companies worldwide. Driven by scientific excellence, trusted service, and uncompromising data quality, Novogene empowers researchers to accelerate discoveries across genomics, transcriptomics, proteomics, metabolomics, and beyond. As a pioneer in multi-omics, Novogene is committed to being your trusted partner in navigating the future of life science innovation.
Korea Herald
6 hours ago
- Korea Herald
KANEKA UBIQUINOL™ WINS COVETED MARKETING AWARD 2025 AT NATURAL HEALTH PRODUCTS NEW ZEALAND SUMMIT
SYDNEY, June 23, 2025 /PRNewswire/ -- Kaneka Corporation Supplement Division APAC, the world-renowned manufacturer and global supplier of Ubiquinol is thrilled to announce that Kaneka Ubiquinol™ has been awarded the prestigious Forbes Packaging Marketing Award 2025 at the Natural Health Products New Zealand (NHPNZ) Summit, further elevating the brand's position and stature in the natural health industry across the APAC region. The win reflects Kaneka Ubiquinol's outstanding efforts in shining the spotlight on the role of mitochondrial health powered by Ubiquinol, in supporting optimal wellbeing. The award celebrates the strategic impact, scientific credibility and executional excellence of its multi-channel marketing programs which have worked to reach, engage and build trust with brandholders, healthcare professionals, pharmacists, media and consumers alike. As a result this has helped position mitochondrial health and Ubiquinol as the new frontier of evidence-based wellbeing. Mitochondria, powered by the naturally occurring antioxidant ubiquinol, are the millions of "powerhouses" found in all cells that generate energy in our body. They are found in the largest concentrations in tissues and organs requiring the highest levels of energy production – heart, brain, liver, lungs, muscles, sperm and ovum. Science shows that from the age of approximately 30 + natural Ubiquinol levels start to decline, which may require supplementation. Kaneka Ubiquinol's unique globally patented precision yeast fermentation process enables the production of bioidentical Ubiquinol, delivering a premium, clinically proven ingredient that supports mitochondrial health. Upon receiving the award Tsuyoshi Takakuwa, Head of Marketing & Sales (APAC) Supplemental Nutrition Business Division, Kaneka Corporation, Japan said "this recognition reflects the collective efforts of our marketing, science, R&D teams, healthcare practitioner partners, brandholders, KOLs and, importantly consumers, united by a shared commitment to science, quality, education and a long-term vision to cement Ubiquinol's role as the foundation of mitochondrial health." On congratulating the team, Kazuki Takita, Oceania & Asia Marketing & Sales Team, Supplement Business Group, Supplement Strategic Unit, added that the award is a powerful testament of the success of the brand's multi-market, multi-channel strategy, which supports Kaneka Ubiquinol's presence and credibility across the APAC region. "This award illustrates our strategic vision: to position Kaneka Ubiquinol™ as a trusted ingredient for healthcare professionals, a premium asset for brandholders, and a clinically supported ingredient for consumers seeking high-quality, evidence-based supplementation to support their overall health and wellbeing," he continued. "Thank you to NHPNZ and the judging panel for this honour and we extend our congratulations to all the other finalists and winners." ABOUT KANEKA UBIQUINOL™ Kaneka Ubiquinol™ is supported by 100+ scientific studies, 80+ patents and 45+ years of research, with applications spanning mitochondrial health, cardiovascular health, cognitive function, women's health, reproductive health, energy production, sleep, stress, healthy ageing and vitality. Kaneka Ubiquinol's impeccable standards are built on the Japanese philosophy of 'Kaizen' meaning 'a commitment to quality, efficiency and pursuit of perfection', from the company's rigorous commitment to quality and research, to their outstanding stakeholder support. Its strict adherence to the highest manufacturing standards guarantees a stable ingredient, free from impurities, meeting rigorous standards and sustainability requirements, setting the global benchmark for production quality. Listed in over 50 countries in 1000+ practitioner and OTC nutraceutical brands since 2006.
Korea Herald
2 days ago
- Korea Herald
Hong Kong Airlines Celebrates Inaugural Flight to Sydney
Offering Travellers More Direct Flight Options to Australia HONG KONG, June 21, 2025 /PRNewswire/ -- Hong Kong Airlines' inaugural flight between Hong Kong and Sydney, Australia, departed yesterday, making it the second local airline to operate this route and providing greater travel options for business, leisure, and transit passengers. To mark this new milestone in its network expansion, Hong Kong Airlines held celebratory events at both Hong Kong International Airport (HKIA) and Sydney Airport (SYD). Prior to departure, a launch ceremony was held at the boarding gate of the HKIA. The event was attended by distinguished guests, including Mr Jeff Sun, President of Hong Kong Airlines; Mr Ian McGraw from the Australian Consulate-General in Hong Kong; Ms Carmen Tam and Ms Vivien Yuen from Tourism Australia; Ms Jennifer Tung from Destination New South Wales; and Mr Ricky Chong from Airport Authority Hong Kong. The guests interacted with passengers and presented them with bespoke souvenirs to commemorate the historic occasion. During the event, Hong Kong Airlines President Mr Jeff Sun stated: "As a full-service local carrier, the launch of our Sydney service marks a significant step in our transformation to an international airline. Sydney is not only a popular destination for leisure and business travel but also one of Australia's most vital economic hubs. The expansion of the bilateral traffic rights agreement allows us to offer more choice to travellers in both cities, strengthening the connection between them." He added, "While Hong Kong Airlines may be a younger brand in the mature Australian market, we are endeavouring in our commitment to providing quality service. We operate this route with our Airbus A330 aircraft, featuring comfortable business and economy class cabins, and strive to deliver a passenger-centric in-flight experience through attentive service and fine dining for our long-haul customers." Sydney Airport CEO Mr Scott Charlton said: "We're proud to welcome Hong Kong Airlines to Sydney as our 52nd airline partner with its strong reputation for service excellence, efficiency and value. This inaugural service comes on the back of the first expansion in bilateral air traffic rights between Australia and Hong Kong in 19 years and we thank the Albanese Federal Government for its role in enabling this important agreement, which reflects the strength of our longstanding cultural and economic ties." NSW Minister for Jobs and Tourism Steve Kamper, said: "Hong Kong is a priority international market for NSW, with incoming travellers contributing substantially to the NSW visitor economy. The Minns Labor Government has made it very clear; we want to grow our visitor economy and the best way to do this is by increasing airline capacity and unlocking new international markets for NSW. We've set our sights on increasing the state's aviation capacity by 8.5 million seats, and this new Hong Kong route will complement other new routes we're securing as we work towards landing this goal." Mr Wang Yu, Consul General of People's Republic of China (Sydney), said: "As the second Hong Kong-based airline to operate the Hong Kong–Sydney route, Hong Kong Airlines not only provides a convenient new option for traveling between China and Australia, but also contributes to enhanced exchanges among students, tourists, business professionals and friends from all walks of life. This new service will strengthen Hong Kong and Sydney's role as vital gateways for the flow of people and goods, injecting fresh momentum into the economic and cultural ties between China and Australia. Its launch will also attract more international travelers to transit through Hong Kong or Sydney, further strengthening both cities' positions as global aviation hubs and creating new opportunities for trade and investment. Looking ahead, the Consulate-General of China in Sydney will continue to encourage and support airlines from both China and Australia in restoring or launching new routes based on the principle of mutual benefit and win-win cooperation. We believe that Hong Kong Airlines will continuously enhance its service quality and showcase a good corporate image." Also in attendance at the Sydney welcome ceremony were representatives from the Consulate-General of the People's Republic of China in Sydney, Destination NSW and the Hong Kong Economic and Trade Office (Sydney). Exclusive Lounge Access for Connecting Passengers To celebrate the launch of the new service, passengers travelling on this route and transit at Hong Kong for selected Hong Kong Airlines flights* to Vancouver, Bali, Tokyo, Osaka, Fukuoka, Shanghai (Pudong), Haikou, or Sanya, between 20 June and 31 October 2025, will receive complimentary access to the airline's flagship lounge "Club Autus" at Hong Kong International Airport. *Please click here for the relevant terms and conditions. Expanding Route Network The launch of the Sydney service indicates Hong Kong Airlines' overarching strategy for its network expansion. Coupled with the various significant destinations that have been inaugurated or reinstated since the start of the year, including Gold Coast in Australia, Vancouver in Canada, and Hulunbuir in Inner Mongolia of mainland China, the airline has cultivated a more extensive and diversified route map. This further underscores Hong Kong Airlines' commitment and contribution to the aviation industry's recovery and long-term development. In addition to the new routes, the Company also increased the frequency of services on multiple routes to cater to the summer travel demand. This includes the resumption of seasonal flights to the Maldives and an increase in flights to Da Nang to two per day. Additionally, flights to Shanghai Pudong will be increased to four per day, while services to Hangzhou and Nanjing will become twice day. The variety of flight times available throughout the day provides business, leisure, and transit passengers with the flexibility to plan their itineraries. The Company will launch another new service in July, providing passengers with more travel options. Hong Kong Airlines flight schedule* between Hong Kong and Sydney is as follows (All times local): Please download high-resolution photos through this link. About Hong Kong Airlines Established in 2006, Hong Kong Airlines is a full-service airline firmly rooted in Hong Kong. The airline flies to over 30 destinations across the Asia Pacific and North America, and currently maintains interline and codeshares with multiple airline partners and ferry service providers. Hong Kong Airlines operates an all-Airbus fleet. It has been awarded the internationally acclaimed four-star rating from Skytrax since 2011. For more information, please visit or our social media channels on LinkedIn, Twitter, Instagram and Facebook.
